Leonardo Roever: A Consensus Framework for Biomarker Research and Clinical Translation in Stroke
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn about a recent article by Steffen Tiedt et al, published in The Lancet Neurology:
”Biomarkers for Advancing Stroke Diagnosis and Prognosis
The complexity and incomplete understanding of stroke pathophysiology represent substantial challenges for personalized healthcare and the development of new therapies, as reflected in the neutral results of many randomized clinical trials.
Current clinical algorithms lack the precision needed to diagnose stroke before hospital admission, predict disease progression and recovery, or assess the risk of recurrence.
Biomarkers are urgently needed, but the absence of a robust evidence base hinders their clinical translation.
To lay the groundwork for filling this knowledge gap, an international multidisciplinary panel of stroke experts conducted a literature review that formed the basis for a Delphi consensus process.
The stroke expert panel proposes 17 research priorities and five minimum datasets for stroke biomarker studies, each corresponding to a key domain of stroke care: pre-hospital diagnosis, ischemic stroke progression, atrial heart disease, atherosclerotic plaque vulnerability, and intracerebral hemorrhage.
This framework will promote consistency and collaboration for the discovery, validation, and clinical translation of biomarkers to improve stroke care.”
Title: Biomarkers for advancing diagnosis and prognosis in stroke
Authors: Steffen Tiedt, Alejandro Bustamante, Alan Cameron, Pol Camps-Renom, Gerrit M Grosse, Johanna Ospel, Bastian Volbers, Heinrich J Audebert, Julia Aulin, Bastian Cheng, Charlotte Cordonnier, Jonathan M Coutinho, Ana Catarina Fonseca, Michael D Hill, Märit Jensen, Christina Jern, Joseph Kamtchum-Tatuene, Mira Katan, Peter J Kelly, Anna Kopczak, Robin Lemmens, Arne G Lindgren, James J M Loan, Christian H Nolte, Laurent Puy, Luca Saba, Rustam Al-Shahi Salman, Else Charlotte Sandset, Magdy H Selim, Pierre Seners, Nikola Sprigg, Hsin-Hsi Tsai, Karen M Doyle, Joan Montaner, Floris H B M Schreuder, Luciano Sposato, Neshika Samarasekera, John J McCabe on behalf of the BIOSTROKE investigators
Read the Full Article on The Lancet Neurology
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 19, 2026, 18:29Rameez Ashraff: Have You Noticed Neutrophil Inclusions in a Thrombocytopenia Smear?
-
Mar 19, 2026, 17:49Matteo Foschi: Breaktrough Stroke on Oral Anticoaugulants for Atrial Fibrillation
-
Mar 19, 2026, 17:30UK Haemophilia Society Continues to Empower Individuals and Families Through Advocacy, Education, and Community Support – WFH
-
Mar 19, 2026, 17:20Dimitrios Nikas: Stroke During TAVI Procedures Still Remains Noticeable High
-
Mar 19, 2026, 17:14Akinchan Bhardwaj: Differences in Bleeding Outcomes Among DOACs
-
Mar 19, 2026, 17:03How Personal Experiences Can Support Self‑Advocacy and Help Improve Healthcare Outcomes – Hemophilia Alliance
-
Mar 19, 2026, 16:54X. Long Zheng: Unpacking the Real-World Challenges of ADAMTS13 on ISTH Pulse Podcast
-
Mar 19, 2026, 16:50Zain Khalpey: Predictive Imaging and AI in Aortic Dissection Risk Assessment
-
Mar 19, 2026, 16:49Marilena Vrana: Access, Resilience, and Policy Priorities Ahead of IPPC2026